Inotek Pharmaceuticals (United States)
Inotek Pharmaceuticals is a clinical-stage biopharmaceutical company based in Lexington, Massachusetts focused on the discovery, development and commercialization of novel therapies to treat glaucoma and other serious diseases of the eye. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Inotek Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
48%
Total
Publications
329
Total Open
Publications
157
Total
Citations
21K
Open Access
Percentage
48%
Total
Publications
329
Total Open
Publications
157
Total
Citations
21K
Breakdown
Publisher Open
23%
Both
13%
Other Platform Open
12%
Closed
52%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 34%
41
Hybrid 11%
13
No Guarantees 55%
67
Other Platform Open
Institution 65%
55
Domain 45%
38
Other Internet 7%
6
Public 1%
1
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 38 |
University of Debrecen | Institution | 22 |
National Institutes of Health | Institution | 9 |
doaj.org OAI-PMH Repository | Institution | 8 |
unil.ch OAI-PMH Repository | Institution | 4 |
Swiss School of Archaeology in Greece | Institution | 4 |
DOI | Other Internet | 4 |
Istanbul University | Institution | 3 |
Unknown Repository | Other Internet | 2 |
University of Michigan | Institution | 2 |